142 related articles for article (PubMed ID: 7637328)
41. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro.
Andrews PW; Damjanov I; Simon D; Banting GS; Carlin C; Dracopoli NC; Føgh J
Lab Invest; 1984 Feb; 50(2):147-62. PubMed ID: 6694356
[TBL] [Abstract][Full Text] [Related]
42. Four new human germ cell tumor cell lines.
Teshima S; Shimosato Y; Hirohashi S; Tome Y; Hayashi I; Kanazawa H; Kakizoe T
Lab Invest; 1988 Sep; 59(3):328-36. PubMed ID: 2842544
[TBL] [Abstract][Full Text] [Related]
43. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
Maerz WJ; Baselga J; Reuter VE; Mellado B; Myers ML; Bosl GJ; Spinella MJ; Dmitrovsky E
Oncogene; 1998 Aug; 17(6):761-7. PubMed ID: 9715278
[TBL] [Abstract][Full Text] [Related]
44. Telencephalic transplants in mice: characterization of growth and differentiation patterns.
Isenmann S; Brandner S; Sure U; Aguzzi A
Neuropathol Appl Neurobiol; 1996 Apr; 22(2):108-17. PubMed ID: 8732186
[TBL] [Abstract][Full Text] [Related]
45. Human umbilical cord blood-derived cells differentiate into hepatocyte-like cells in the Fas-mediated liver injury model.
Nonome K; Li XK; Takahara T; Kitazawa Y; Funeshima N; Yata Y; Xue F; Kanayama M; Shinno E; Kuwae C; Saito S; Watanabe A; Sugiyama T
Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1091-9. PubMed ID: 16051923
[TBL] [Abstract][Full Text] [Related]
46. Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells.
Newman MB; Misiuta I; Willing AE; Zigova T; Karl RC; Borlongan CV; Sanberg PR
Stem Cells Dev; 2005 Feb; 14(1):29-43. PubMed ID: 15725742
[TBL] [Abstract][Full Text] [Related]
47. Human embryonal carcinoma grown in athymic mice and in vitro.
Tveit KM; Fodstad O; Brøgger A; Olsnes S
Cancer Res; 1980 Mar; 40(3):949-53. PubMed ID: 7471109
[TBL] [Abstract][Full Text] [Related]
48. Characterization of NTera2/D1 cells as a model system for the investigation of cannabinoid function in human neurons and astrocytes.
Goodfellow CE; Graham SE; Dragunow M; Glass M
J Neurosci Res; 2011 Oct; 89(10):1685-97. PubMed ID: 21674570
[TBL] [Abstract][Full Text] [Related]
49. Reduction of connexin43 expression and dye-coupling during neuronal differentiation of human NTera2/clone D1 cells.
Bani-Yaghoub M; Bechberger JF; Naus CC
J Neurosci Res; 1997 Jul; 49(1):19-31. PubMed ID: 9211986
[TBL] [Abstract][Full Text] [Related]
50. [Fundamental studies on differentiation inducers using a human embryonal carcinoma model].
Yamazawa K; Sekiya S; Kimura H; Shirasawa H; Kawata M; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Oct; 43(10):1303-9. PubMed ID: 1955781
[TBL] [Abstract][Full Text] [Related]
51. Apoptosis as a specific biomarker of diazinon toxicity in NTera2-D1 cells.
Aluigi MG; Guida C; Falugi C
Chem Biol Interact; 2010 Sep; 187(1-3):299-303. PubMed ID: 20338157
[TBL] [Abstract][Full Text] [Related]
52. Chemically induced differentiation of murine embryonal carcinoma in vivo: transplantation of differentiated tumors.
Speers WC; Altmann M
Cancer Res; 1984 May; 44(5):2129-35. PubMed ID: 6201266
[TBL] [Abstract][Full Text] [Related]
53. 22R-Hydroxycholesterol induces differentiation of human NT2 precursor (Ntera2/D1 teratocarcinoma) cells.
Yao ZX; Han Z; Xu J; Greeson J; Lecanu L; Papadopoulos V
Neuroscience; 2007 Aug; 148(2):441-53. PubMed ID: 17689017
[TBL] [Abstract][Full Text] [Related]
54. Production of human CNS neurons from embryonal carcinoma cells using a cell aggregation method.
Cheung WM; Fu WY; Hui WS; Ip NY
Biotechniques; 1999 May; 26(5):946-8, 950-2, 954. PubMed ID: 10337488
[TBL] [Abstract][Full Text] [Related]
55. Immature human NT2 cells grafted into mouse brain differentiate into neuronal and glial cell types.
Ferrari A; Ehler E; Nitsch RM; Götz J
FEBS Lett; 2000 Dec; 486(2):121-5. PubMed ID: 11113451
[TBL] [Abstract][Full Text] [Related]
56. GABA(A) receptors expressed in undifferentiated human teratocarcinoma NT2 cells differ from those expressed by differentiated NT2-N cells.
Neelands TR; Zhang J; Macdonald RL
J Neurosci; 1999 Aug; 19(16):7057-65. PubMed ID: 10436060
[TBL] [Abstract][Full Text] [Related]
57. Differential gene expression between human neurons and neuronal progenitor cells in culture: an analysis of arrayed cDNA clones in NTera2 human embryonal carcinoma cell line as a model system.
Satoh J; Kuroda Y
J Neurosci Methods; 2000 Jan; 94(2):155-64. PubMed ID: 10661835
[TBL] [Abstract][Full Text] [Related]
58. A correlation between the capacity of cavity formation and the subsequent differentiation of teratocarcinoma embryoid body lines.
Uno K
J Embryol Exp Morphol; 1982 Jun; 69():127-40. PubMed ID: 6750025
[TBL] [Abstract][Full Text] [Related]
59. Characterization of the NT2-derived neuronal and astrocytic cell lines as alternative in vitro models for primary human neurons and astrocytes.
Haile Y; Fu W; Shi B; Westaway D; Baker G; Jhamandas J; Giuliani F
J Neurosci Res; 2014 Sep; 92(9):1187-98. PubMed ID: 24801011
[TBL] [Abstract][Full Text] [Related]
60. Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation.
Nelson PT; Kondziolka D; Wechsler L; Goldstein S; Gebel J; DeCesare S; Elder EM; Zhang PJ; Jacobs A; McGrogan M; Lee VM; Trojanowski JQ
Am J Pathol; 2002 Apr; 160(4):1201-6. PubMed ID: 11943704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
